Related Experiment Videos
Melatonin serum levels in rheumatoid arthritis
A Sulli1, G J M Maestroni, B Villaggio
1Laboratory and Division of Rheumatology, Department of Internal Medicine and Medical Specialities, University of Genova, Genova, Italy. mcutolo@unige.it
Annals of the New York Academy of Sciences
|July 13, 2002
Summary
Melatonin (MLT) levels are higher in rheumatoid arthritis (RA) patients, peaking earlier in the morning. This may explain RA
Area of Science:
- Immunology
- Endocrinology
- Rheumatology
Background:
- Melatonin (MLT) influences the immune system, activating cells and promoting inflammatory responses.
- Cytokines, modulated by MLT, play a key role in rheumatoid arthritis (RA) synovial inflammation.
- RA symptoms like morning stiffness correlate with early morning inflammatory peaks.
Purpose of the Study:
- To investigate nocturnal serum melatonin (MLT) levels in rheumatoid arthritis (RA) patients compared to healthy controls.
- To explore the relationship between MLT secretion patterns and RA clinical manifestations.
Main Methods:
- Nocturnal serum MLT levels were measured in 10 RA patients and 6 healthy controls.
- Blood samples were collected at multiple time points from 8 p.m. to 8 a.m.
- MLT concentrations were analyzed and compared between groups and across time points.
Main Results:
- RA patients exhibited higher MLT serum levels at 8 p.m. and 8 a.m. compared to controls.
- MLT levels peaked earlier in RA patients (before 2 a.m.) than in controls.
- RA patients showed a prolonged MLT plateau, unlike healthy subjects.
Conclusions:
- Elevated and altered MLT secretion patterns in RA patients may contribute to early morning inflammatory symptoms.
- The imbalance between lower cortisol and higher MLT levels could be implicated in RA pathogenesis.
- MLT's neuroimmunomodulatory effects on synovitis warrant further investigation in RA management.